These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18577760)

  • 1. Zonisamide concentrations during pregnancy.
    Oles KS; Bell WL
    Ann Pharmacother; 2008 Jul; 42(7):1139-41. PubMed ID: 18577760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of zonisamide on the electroencephalogram of a patient with juvenile myoclonic epilepsy.
    Szaflarski JP
    Epilepsy Behav; 2004 Dec; 5(6):1024-6. PubMed ID: 15582856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential efficacy of zonisamide in refractory juvenile myoclonic epilepsy: retrospective evidence from an Irish compassionate-use case series.
    O'Rourke D; Flynn C; White M; Doherty C; Delanty N
    Ir Med J; 2007 Apr; 100(4):431-3. PubMed ID: 17566478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital.
    Endo S; Hagimoto H; Yamazawa H; Kajihara S; Kubota S; Kamijo A; Nakajima K; Furusho R; Miyauchi T; Endo M
    Epilepsia; 2004; 45 Suppl 8():42-7. PubMed ID: 15610194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialyzability of the antiepileptic drug zonisamide in patients undergoing hemodialysis.
    Ijiri Y; Inoue T; Fukuda F; Suzuki K; Kobayashi T; Shibahara N; Takenaka H; Tanaka K
    Epilepsia; 2004 Aug; 45(8):924-7. PubMed ID: 15270757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zonisamide suppresses the tonic phase but not the clonic phase of generalized seizures in developing rats.
    Mareš P
    Epilepsy Res; 2010 Dec; 92(2-3):244-8. PubMed ID: 20947303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of zonisamide: our experience.
    Yamauchi T; Aikawa H
    Seizure; 2004 Dec; 13 Suppl 1():S41-8; discussion S49. PubMed ID: 15511689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute seizures due to a probable interaction between valproic acid and meropenem.
    Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
    Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of zonisamide in refractory childhood-onset epilepsy.
    Kluger G; Zsoter A; Holthausen H
    Eur J Paediatr Neurol; 2008 Jan; 12(1):19-23. PubMed ID: 17574461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide: a new antiepileptic drug.
    Oommen KJ; Mathews S
    Clin Neuropharmacol; 1999; 22(4):192-200. PubMed ID: 10442247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy.
    Kondo T; Kaneko S; Amano Y; Egawa I
    Epilepsia; 1996 Dec; 37(12):1242-4. PubMed ID: 8956859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs.
    Orito K; Saito M; Fukunaga K; Matsuo E; Takikawa S; Muto M; Mishima K; Egashira N; Fujiwara M
    J Vet Pharmacol Ther; 2008 Jun; 31(3):259-64. PubMed ID: 18471148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam.
    Garrity LC; Turner M; Standridge SM
    Pharmacotherapy; 2014 Jul; 34(7):e128-32. PubMed ID: 24807683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study.
    Vossler DG; Conry JA; Murphy JV;
    Epileptic Disord; 2008 Mar; 10(1):31-4. PubMed ID: 18367429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate toxic effects following acute zonisamide overdose.
    Hofer KE; Trachsel C; Rauber-Lüthy C; Kupferschmidt H; Kullak-Ublick GA; Ceschi A
    Epilepsy Behav; 2011 May; 21(1):91-3. PubMed ID: 21463969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide monotherapy for idiopathic epilepsy in dogs.
    Chung JY; Hwang CY; Chae JS; Ahn JO; Kim TH; Seo KW; Lee SY; Youn HY
    N Z Vet J; 2012 Nov; 60(6):357-9. PubMed ID: 22639873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide therapy for refractory idiopathic epilepsy in dogs.
    Dewey CW; Guiliano R; Boothe DM; Berg JM; Kortz GD; Joseph RJ; Budsberg SC
    J Am Anim Hosp Assoc; 2004; 40(4):285-91. PubMed ID: 15238558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.